HBIO Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Harvard Bioscience Inc

Watchlist Manager

Watchlist

Price: 5.93 USD -3.1% Market Closed

Market Cap: $26.7m

	Harvard Bioscience Inc NASDAQ:HBIO	US
K	Komercni Banka as DUS:KONN	CZ
B	Berdikari Pondasi Perkasa Tbk PT IDX:BDKR	ID
R	Rhoen Klinikum AG XBER:RHK	DE
E	Equity Residential SWB:EQR	US
	Prysmian SpA F:AEU	IT
	Afry AB STO:AFRY	SE
S	Sinopharm Group Co Ltd XMUN:X2S	CN
	Altius Renewable Royalties Corp TSX:ARR	CA
F	Franklin Electric Co Inc F:FE4	US
I	Invesco Ltd LSE:0UAN	US
C	Chevron Corp LSE:0R2Q	US

Profitability Summary

Harvard Bioscience Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

58%

Strong 3Y Average Gross Margin

58%

Gross Margin is Increasing

55% > 58%

Negative Operating Margin

-1%

Negative 3Y Average Operating Margin

-3%

Operating Margin is Increasing

-2% > -1%

Negative Net Margin

-66%

Negative 3Y Average Net Margin

-28%

Declining Net Margin

-5% > -66%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

6% > 6%

Negative ROE

-147%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-2%

ROIC is Increasing

-1% > 0%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.